August 30, 2016 — Medtronic plc announced results from the...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
News | Cardiac Resynchronization Therapy Devices (CRT) | August 30, 2016
St. Jude Medical said recent claims of the cyber attack vulnerability of its [email protected] remote monitoring system and its implantable EP devices are not true.
Feature | EP Lab | August 29, 2016 | Dave Fornell
August 29, 2016 — Investment research firm Muddy Waters Capital released a report Aug. 25 saying it believes St....
News | Antiplatelet and Anticoagulation Therapies | August 16, 2016
August 16, 2016 — Warfarin prescribed to prevent strokes in...
Sponsored Content
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.
Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the...
Technology | Ablation Systems | August 15, 2016
August 15, 2016 — The U.S. Food and Drug Administration has granted market approval for the Biosense Webster...
Technology | Implantable Cardioverter Defibrillator (ICD) | August 09, 2016
August 9, 2016 — The U.S. Food and Drug Administration (FDA) granted market approval for the Emblem MRI Subcutaneous...
An illustration of a Watchman transcatheter LAA occluder being implanted.
Feature | Left Atrial Appendage (LAA) Occluders | August 01, 2016 | Dave Fornell
Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in...
Sponsored Content
An example of the new generation of cardiac monitoring device that is replacing Holter monitoring is the Cardea Solo wearable sensor. The FDA-cleared device automatically analyzes data when the device is turned back into the physician's office and automatically produces a draft summary report. This technology can simplify the workflow by eliminating the need for third-party involvement.
Feature | Atrial Fibrillation | September 13, 2018
Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time...
News | Blood Testing | July 12, 2016
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. will...
Feature | Antiplatelet and Anticoagulation Therapies | July 26, 2016 | Heidi Olson, Pharm.D
With the recent introduction of several novel oral...
News | EP Mapping and Imaging Systems | July 07, 2016
July 7, 2016 — Abbott recently announced positive results from three clinical studies investigating the benefits...
Sponsored Content
An example of an automated summary cardiac monitor report from Medicalgorithmics' PocketECG system. Most of the the report parameters can be opened as separate pages with additional automated report summaries and graphical data charts.
Blog | Remote Monitoring | June 20, 2018
There is a movement toward real-time, remote cardiac monitoring with the latest generation of...
News | Left Atrial Appendage (LAA) Occluders | July 07, 2016
July 7, 2016 — AtriCure Inc. announced the first patient has been enrolled in the FROST study at William Beaumont...
News | Left Atrial Appendage (LAA) Occluders | July 05, 2016
July 5, 2016 — AtriCure Inc. announced that it has received CE Mark for the AtriClip PRO2 Left Atrial Appendage (LAA...
News | Cardiovascular Clinical Studies | June 28, 2016
June 28, 2016 — New research shows patients admitted to National Health Service (NHS) hospitals in the United...
Sponsored Content
New cardiac monitoring technologies allow for longer duration data collection. The Medtronic Reveal Linq implantable cardiac monitor allows for 24/7 monitoring for up to three years. This might not be necessary for most patients, and there are several newer Holter monitors that can record up to several days or several weeks of data in real-time.
Blog | ECG Wireless Remote Access | May 23, 2018
New patient monitoring technologies with wireless connectivity have enabled a revolution in cardiac event and...
News | Antiplatelet and Anticoagulation Therapies | June 24, 2016
June 24, 2016 — More than 1 in 3 ...
News | Antiplatelet and Anticoagulation Therapies | May 25, 2016
May 25, 2016 — Technavio’s latest report on the U.S....
